Gene One Life Science

Gene One Life Science Current Assets

The Current Assets of Gene One Life Science (011000.KS) as of Oct 26, 2026 is 15.63 B KRW. In the previous year, Current Assets was 28.64 B KRW — a change of -45.41% (lower).

Current Assets

15.63 BKRW

YoY

-45.41%

Last updated:

Current Assets of Gene One Life Science is 2025 15.63 B KRW. Current Assets of Gene One Life Science was 2024 28.64 B KRW. It decreases by -45.41% lower compared to the previous year.

The Gene One Life Science Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
39.46 B KRW
Jan 1, 2019
36.60 B KRW
Jan 1, 2020
108.72 B KRW
Jan 1, 2021
133.78 B KRW
Jan 1, 2022
72.98 B KRW
Jan 1, 2023
35.52 B KRW
Jan 1, 2024
28.64 B KRW
Jan 1, 2025
15.63 B KRW
The Gene One Life Science Current Assets history
YEARCurrent AssetsYoY
15.63 BKRW-45.41%
28.64 BKRW-19.39%
35.52 BKRW-51.33%
72.98 BKRW-45.45%
133.78 BKRW+23.06%
108.72 BKRW+197.07%
36.60 BKRW-7.27%
39.46 BKRW+10.54%
35.70 BKRW-33.69%
53.84 BKRW+49.69%
35.97 BKRW+19.48%
30.10 BKRW+47.38%
20.43 BKRW-32.22%
30.13 BKRW+33.70%
22.54 BKRW-3.92%
23.46 BKRW-41.09%
39.83 BKRW+88.25%
21.16 BKRW-38.44%
34.37 BKRW+2.24%
33.61 BKRW+322.90%
7.95 BKRW-15.53%
9.41 BKRW+3.34%
9.11 BKRW-9.65%
10.08 BKRW+12.15%
8.99 BKRW-27.21%
12.34 BKRW+17.16%
10.54 BKRW-2.57%
10.81 BKRW-20.15%
13.54 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Gene One Life Science Stock analysis

What does Gene One Life Science do? GeneOne Life Science, Inc. generates revenue through its biomedical contract manufacturing organization (CMO) services, producing DNA vaccines for disease prevention and treatment. The company also sells wicks under the brand INTERON for use in dress shirts, suits, and caps, and provides biopharmaceutical services including research, development, and manufacturing of plasmid DNA and DNA vaccines. Its leasing business involves nonresidential buildings. The primary buyers for the biomedical CMO services are likely pharmaceutical companies seeking contract manufacturing for DNA vaccines. INTERON wicks are purchased by apparel manufacturers producing dress shirts, suits, and caps. The leasing segment targets commercial property tenants requiring nonresidential space. The company serves the biomedical, textile, and real estate sectors through these distinct business segments. Gene One Life Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Gene One Life Science stock

Current Assets of Gene One Life Science is 15.63 B KRW in 2025.

Current Assets of Gene One Life Science changed from 28.64 B KRW to 15.63 B KRW, representing a -45.41% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Gene One Life Science since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Gene One Life Science historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Gene One Life Science

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Gene One Life Science